Jay Y Spiegel

11PUBLICATIONS
93CO-AUTHORS
Haematological tumoursBiomedical engineering not elsewhere classifiedImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 28, 2026
Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

|Jun 29, 2026
False-positive HIV-1 RNA detection following obecabtagene autoleucel.

|Feb 05, 2026
Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era.

Christopher M Lopez, Jose F Suarez, Maria A Mendoza

|Apr 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.

Khushali Jhaveri, Ram Thapa, Dalia Ercan

|Aug 02, 2024
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.

Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil

|Jun 05, 2024
Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy.

Rick Y Lin, Anthony D Anderson, Yoichiro Natori

Pageof 2

Frequent Collaborators

5 joint publications

David Miklos

4 joint publications

Anthony D Anderson

4 joint publications

Trent Wang

4 joint publications

Michael D Jain